Strides Pharma Science Limited said that Strides Pharma Global Pte. Limited, Singapore, its step-down fully-owned subsidiary, has secured approval for Oseltamivir Phosphate for Oral Suspension,6 mg/mL from the US Food & Drug Administration (FDA). The drug is bioequivalent and therapeutically equivalent to Tamiflu for Oral Suspension, 6 mg/mL, of Hoffmann-La Roche (Roche). As per IQVIA […]
Roche India said that India’s Central Drugs Standards Control Organisation (CDSCO) has granted an emergency use authorisation (EUA) for the Casirivimab, Imdevimab antibody cocktail for the treatment of Covid-19. The EUA will now allow Roche to import the globally manufactured product batches of Casirivimab/Imdevimab to India, which will be marketed and distributed in the country […]
Swiss healthcare company Roche has launched the Elecsys Anti-p53 immunoassay to help in the diagnosis of various types of cancer by the in vitro quantitative determination of anti-p53 antibodies. The Anti-p53 immunoassay test will help physicians in diagnosing oesophageal cancer, breast cancer, and bowel cancer in patients, in combination with other diagnostic tests, said Roche. […]
Roche has agreed to acquire US-based molecular diagnostic solutions provider GenMark Diagnostics for $24.05 per share or about $1.8 billion in an all-cash deal. GenMark Diagnostics offers molecular diagnostic tests that can detect multiple pathogens from a single patient sample. According to Roche, the syndromic panel testing portfolio of GenMark Diagnostics will complement its current […]
Roche acquisition of Inflazome : Swiss drug giant Roche has acquired Irish biotech company Inflazome, a developer of inflammasome inhibitors, for an upfront payment of €380 million. The Irish pharma company will also stand to get additional contingent payments, which will be based on the meeting of certain predetermined milestones. Inflazome was a portfolio company […]
Belgian pharma company UCB has signed a global exclusive license deal worth up to $2 billion for its Alzheimer’s Disease drug candidate (AD drug candidate) UCB0107 with Roche and its subsidiary Genentech. UCB0107 is a monoclonal antibody drug candidate, which is being developed by UCB as a potential therapy for patients with progressive supranuclear palsy […]
Swiss pharma giant Roche and US precision therapy company Blueprint Medicines have entered into a worldwide licensing and collaboration deal potentially worth up to $1.703 billion for the latter’s cancer drug candidate pralsetinib. Through the deal, Roche gains exclusive rights for the co-development and marketing of the investigational drug for RET-altered cancers across the world […]
Roche has secured approval from the US Food and Drug Administration (FDA) for its cobas EZH2 Mutation Test as a companion diagnostic for TAZVERIK (tazemetostat), developed by Epizyme. According to the Swiss healthare company, the molecular test can detect abnormalities in the EZH2, or Enhancer of Zeste Homolog 2, gene in patients having follicular lymphoma […]
Roche acquisition of Stratos Genomics : Swiss pharma giant Roche has acquired US-based early-stage DNA sequencing technology company Stratos Genomics for an undisclosed price. The transaction is expected to help Roche advance the development of its nanopore sequencer through the access to Sequencing by Expansion (SBX), Stratos Genomics’ unique chemistry. Roche said that once developed, […]
Swiss healthcare company Roche has launched a new blood gas digital solution called Roche v-TAC, which is said to be designed to enhance patient care. The new digital diagnostic solution is said to help clinicians to get better results for arterial blood gas values from patients having respiratory or metabolic abnormalities by using a less […]